Some people with schizophrenia do live without antipsychotic medication, but the outcomes vary enormously depending on individual factors, and the risks of going unmedicated are real. A 20-year longitudinal study found that at any given follow-up point, 30 to 40% of participants with schizophrenia were no longer taking antipsychotics. Some of them did well. Many did not. The honest answer is that living without medication is possible for a subset of people, but it’s not a safe choice for everyone, and there’s currently no reliable way to predict who will thrive without it.
What the Long-Term Research Shows
The most striking data comes from a 20-year study that tracked people with schizophrenia across six follow-up periods. Among those who stopped antipsychotics early (before the two-year mark) and stayed off them for the entire study, 87% experienced two or more periods of recovery. By contrast, among those who took antipsychotics continuously for 15 to 20 years, only 17% ever met the criteria for recovery during any follow-up.
These numbers look dramatic, but they need context. The people who stopped medication early and did well may have had milder forms of the illness to begin with. Researchers couldn’t fully separate whether stopping medication caused better outcomes or whether people with less severe schizophrenia were simply more likely to stop. Starting from the 4.5-year follow-ups onward, those off antipsychotics were significantly less likely to be psychotic and had more favorable protective factors, but that pattern could reflect self-selection as much as a treatment effect.
The Relapse Risk Without Medication
Unmedicated schizophrenia carries a relapse rate of roughly 10% per month. That means in any given year, the odds of experiencing a psychotic episode are high. Antipsychotic medication reduces that rate by 2.5 to 10 times, depending on the individual and the specific drug. For people with a first episode, early drug treatment improves outcomes over the following several years.
Relapse isn’t just an inconvenience. Each psychotic episode can cause measurable brain changes. Research on first-episode psychosis shows that the longer someone goes with active, untreated psychosis, the more gray matter density they lose in brain regions involved in visual processing, memory, and spatial navigation. These structural changes begin early in the illness, which is why most clinicians emphasize treating psychotic episodes quickly rather than waiting them out.
Who Might Manage Without Medication
There are no consistent factors that reliably predict who can discontinue antipsychotics successfully. That’s a key finding from a recent review of the evidence, and it cuts both ways: it means clinicians can’t confidently tell you “you’re safe to stop,” but it also means the option shouldn’t be automatically ruled out for anyone.
In practice, dose reduction or discontinuation is considered more feasible for people who have good insight into their condition, meaning they can recognize when symptoms are returning. Having well-characterized early warning signs of relapse matters, because it gives you and the people around you a chance to intervene before a full episode develops. Candidates typically include those who’ve achieved remission after a first episode, or who’ve been stable across multiple episodes for at least 12 months, and who don’t have significant risk factors for violence or self-harm. A stable social situation, somewhere safe to live, people who check in on you, also makes a meaningful difference.
What Happens to Physical Health
People with schizophrenia die earlier than the general population regardless of medication status. The overall mortality rate is roughly 2.5 to 3.6 times higher than average, with the gap driven by a combination of suicide (especially before age 40, where the risk is over eight times higher), cardiovascular disease, respiratory illness, and digestive conditions. Antipsychotic medications themselves contribute to some of these risks through weight gain and metabolic changes, which complicates the calculation. Staying on medication reduces psychotic episodes but may worsen cardiovascular health. Going off medication removes those metabolic side effects but raises the risk of untreated psychosis and its consequences.
This tradeoff is one reason some people and their treatment teams explore dose reduction rather than full discontinuation, aiming to find the lowest effective dose that controls symptoms without as many physical side effects.
Therapy and Support Without Drugs
Cognitive behavioral therapy for psychosis (CBTp) is the most studied psychological treatment for schizophrenia, but virtually all the clinical evidence examines it alongside antipsychotic medication, not as a replacement. There are almost no rigorous trials of CBTp used alone, which means we don’t have good data on how well it works without drugs. In practice, it’s recommended as an add-on to medication and community mental health services, not a standalone treatment.
That said, psychosocial supports play a significant role in functional recovery. Case management that helps with practical daily tasks like shopping, paying bills, and finding work has a documented impact on outcomes. Employment in particular is associated more strongly with symptom remission and communication skills than with cognitive function alone. A strong support network, stable housing, meaningful daily structure, and access to crisis services can all improve quality of life whether or not someone is taking medication.
Safety Risks of Stopping
A 12-year study of over 112,000 matched cases found that people with schizophrenia who weren’t adhering to medication had roughly 1.5 to 1.9 times the risk of various types of violence compared to those who were adherent. Interestingly, the risk didn’t increase further with higher levels of nonadherence, suggesting the relationship isn’t a simple dose-response. Still, the elevated risk is consistent and statistically significant.
The violence risk affects a minority of people with schizophrenia, but it’s worth understanding honestly. Most of the increased risk involves minor incidents rather than serious criminal behavior. The larger personal danger is to yourself: untreated psychotic episodes can lead to self-harm, inability to care for basic needs, job loss, homelessness, and damaged relationships that are difficult to rebuild.
If You’re Considering Stopping
Abruptly stopping antipsychotics is more dangerous than a gradual, supervised taper. The research supports cautious dose reduction with close monitoring over sudden discontinuation. If you’re considering this path, the practical elements that improve your chances include having someone in your life who can recognize your early warning signs, having a plan for what to do if symptoms return, and maintaining regular contact with a mental health professional even while off medication.
The people in the long-term studies who did well without medication weren’t simply “toughing it out.” They typically had less severe symptom profiles, stronger social connections, and access to support when they needed it. Living with schizophrenia without medication is not impossible, but it requires more structure and vigilance, not less.